Children with infantile neuronal ceroid lipofuscinosis have an increased risk of hypothermia and bradycardia during anesthesia
- PMID: 19608805
- PMCID: PMC2743022
- DOI: 10.1213/ane.0b013e3181aa6e95
Children with infantile neuronal ceroid lipofuscinosis have an increased risk of hypothermia and bradycardia during anesthesia
Abstract
Background: Neuronal ceroid lipofuscinoses (NCLs) are a group of autosomal recessive neurodegenerative diseases characterized by lysosomal accumulation of autofluorescent material in neurons and other cell types. The infantile NCL (INCL) subtype is rare (1 in >100,000 births), the most devastating of childhood subtypes, and is caused by mutations in the gene CLN1, which encodes palmitoyl-protein thioesterase-1.
Methods: To investigate the incidence of hypothermia and bradycardia during general anesthesia in patients with INCL, we conducted a case-control study to examine the perianesthetic course of patients with INCL and of controls receiving anesthesia for diagnostic studies.
Results: Eight children with INCL (mean age 25 mo [range, 10-32] at first anesthetic) and 25 controls (mean age 44 mo [range, 18-92]) underwent 62 anesthetics for nonsurgical procedures. Patients with INCL had neurologic deficits including developmental delay, myoclonus, and visual impairment. Patients with INCL had lower baseline temperature (36.4 +/- 0.1 vs 36.8 +/- 0.1, INCL versus controls, P < 0.007), and during anesthesia, despite active warming techniques, had significantly more hypothermia (18 vs 0 episodes, P < 0.001) and sinus bradycardia (10 vs 1, P < 0.001) compared with controls. INCL diagnosis was significantly associated with temperature decreases during anesthesia (P < 0.001), whereas age, sex, and duration of anesthesia were not (P = NS).
Conclusions: We report that patients with INCL have lower baseline body temperature and during general anesthesia, despite rewarming interventions, are at increased risk for hypothermia and bradycardia. This suggests a previously unknown INCL phenotype, impaired thermoregulation. Therefore, when anesthetizing these children, careful monitoring and routine use of warming interventions are warranted.
Conflict of interest statement
Figures
Similar articles
-
The novel Cln1(R151X) mouse model of infantile neuronal ceroid lipofuscinosis (INCL) for testing nonsense suppression therapy.Hum Mol Genet. 2015 Jan 1;24(1):185-96. doi: 10.1093/hmg/ddu428. Epub 2014 Sep 8. Hum Mol Genet. 2015. PMID: 25205113 Free PMC article.
-
In a model of Batten disease, palmitoyl protein thioesterase-1 deficiency is associated with brown adipose tissue and thermoregulation abnormalities.PLoS One. 2012;7(11):e48733. doi: 10.1371/journal.pone.0048733. Epub 2012 Nov 6. PLoS One. 2012. PMID: 23139814 Free PMC article.
-
Cln3-mutations underlying juvenile neuronal ceroid lipofuscinosis cause significantly reduced levels of Palmitoyl-protein thioesterases-1 (Ppt1)-protein and Ppt1-enzyme activity in the lysosome.J Inherit Metab Dis. 2019 Sep;42(5):944-954. doi: 10.1002/jimd.12106. Epub 2019 May 14. J Inherit Metab Dis. 2019. PMID: 31025705 Free PMC article.
-
Pathogenesis and therapies for infantile neuronal ceroid lipofuscinosis (infantile CLN1 disease).Biochim Biophys Acta. 2013 Nov;1832(11):1906-9. doi: 10.1016/j.bbadis.2013.05.026. Epub 2013 Jun 6. Biochim Biophys Acta. 2013. PMID: 23747979 Free PMC article. Review.
-
Molecular genetics of the neuronal ceroid lipofuscinoses.Epilepsia. 1999;40 Suppl 3:29-32. doi: 10.1111/j.1528-1157.1999.tb00896.x. Epilepsia. 1999. PMID: 10446748 Review.
Cited by
-
Oral cysteamine bitartrate and N-acetylcysteine for patients with infantile neuronal ceroid lipofuscinosis: a pilot study.Lancet Neurol. 2014 Aug;13(8):777-87. doi: 10.1016/S1474-4422(14)70142-5. Epub 2014 Jul 2. Lancet Neurol. 2014. PMID: 24997880 Free PMC article. Clinical Trial.
-
Risks of propofol sedation/anesthesia for imaging studies in pediatric research: eight years of experience in a clinical research center.Arch Pediatr Adolesc Med. 2010 Jun;164(6):554-60. doi: 10.1001/archpediatrics.2010.75. Arch Pediatr Adolesc Med. 2010. PMID: 20530306 Free PMC article.
-
Top-down and bottom-up propagation of disease in the neuronal ceroid lipofuscinoses.Front Neurol. 2022 Nov 11;13:1061363. doi: 10.3389/fneur.2022.1061363. eCollection 2022. Front Neurol. 2022. PMID: 36438942 Free PMC article.
-
Comprehensive functional characterization of murine infantile Batten disease including Parkinson-like behavior and dopaminergic markers.Sci Rep. 2015 Aug 4;5:12752. doi: 10.1038/srep12752. Sci Rep. 2015. PMID: 26238334 Free PMC article.
-
Guidelines on the diagnosis, clinical assessments, treatment and management for CLN2 disease patients.Orphanet J Rare Dis. 2021 Apr 21;16(1):185. doi: 10.1186/s13023-021-01813-5. Orphanet J Rare Dis. 2021. PMID: 33882967 Free PMC article.
References
-
- Haltia M. The neuronal ceroid-lipofuscinoses: from past to present. Biochimica et biophysica acta. 2006;1762:850–6. - PubMed
-
- Mole SE, Williams RE, Goebel HH. Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses. Neurogenetics. 2005;6:107–26. - PubMed
-
- Santavuori P, Vanhanen SL, Sainio K, Nieminen M, Wallden T, Launes J, Raininko R. Infantile neuronal ceroid-lipofuscinosis (INCL): diagnostic criteria. J Inherit Metab Dis. 1993;16:227–9. - PubMed
-
- Camp LA, Verkruyse LA, Afendis SJ, Slaughter CA, Hofmann SL. Molecular cloning and expression of palmitoyl-protein thioesterase. The Journal of biological chemistry. 1994;269:23212–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous